Stockreport

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF AstraZeneca AZN announced the failure of an early-stage lung cancer study on its PD-L1 inhibitor, Imfinzi. Novo Nordisk 's NVO acquired candidate ocedurenone failed in a [Read more]